全球吸入麻醉劑市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計吸入麻醉劑市場將從 2025 年的 24.1 億美元成長到 2034 年的 55 億美元，2026 年至 2034 年的複合年成長率為 9.59%。

隨著外科手術技術的日益精進和普及，吸入麻醉劑的全球市場也隨之成長。吸入麻醉劑透過呼吸系統給藥，用於誘導和維持手術期間的無意識狀態。這些麻醉劑常用於醫院和手術中心需要全身麻醉的手術。

全球手術數量的增加和醫療基礎設施的擴大是推動市場成長的主要因素。吸入式麻醉劑起效迅速，鎮靜作用可控，因此適用於多種醫療程序。此外，麻醉給藥系統和病患監測技術的進步也提高了其安全性和有效性。

隨著外科技術和醫療服務的進步，吸入麻醉劑市場前景仍然光明。對新型麻醉劑配方的研究可望提高病患安全性和縮短復原時間。此外，發展中國家外科醫療服務的普及預計將推動需求成長。隨著醫療保健系統的不斷發展，吸入麻醉劑仍將是現代外科醫療的重要組成部分。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球吸入麻醉劑市場：依藥物類型分類

• 市場分析、洞察與預測
• SEVOFLURANE
• DESFLURANE
• Isoflurane
• 其他

第5章：全球吸入麻醉劑市場：依應用分類

• 市場分析、洞察與預測
• 介紹
• 維護和管理

第6章：全球吸入麻醉劑市場：依最終用途分類

• 市場分析、洞察與預測
• 醫院
• 門診手術中心
• 其他

第7章 全球吸入麻醉劑市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • AbbVie Inc
  • Baxter International Inc
  • Dechra Pharmaceuticals PLC（Halocarbon Life Sciences LLC）
  • Fresenius Kabi AG（Fresenius SE & Co. KGaA）
  • Hikma Pharmaceuticals PLC
  • Jiangsu Hengrui Medicine Co. Ltd
  • Lunan Pharmaceutical Group Co. Ltd
  • Merck KGaA
  • Piramal Enterprises Limited
  • Troikaa Pharmaceuticals Ltd

The Inhalation Anesthesia Market size is expected to reach USD 5.50 Billion in 2034 from USD 2.41 Billion (2025) growing at a CAGR of 9.59% during 2026-2034.

The global inhalation anesthesia market has grown as surgical procedures become more advanced and widely available. Inhalation anesthesia involves the use of anesthetic gases delivered through breathing systems to induce and maintain unconsciousness during surgery. These anesthetics are commonly used in hospitals and surgical centers for procedures requiring general anesthesia.

Market growth is driven by the increasing number of surgeries performed worldwide and the expansion of healthcare infrastructure. Inhalation anesthetics provide rapid onset and controlled sedation, making them suitable for various medical procedures. Improvements in anesthesia delivery systems and patient monitoring technologies have also enhanced safety and effectiveness.

The future outlook for the inhalation anesthesia market remains promising as surgical techniques and healthcare services continue to advance. Research into new anesthetic formulations may improve patient safety and recovery times. Expanding access to surgical care in developing regions is also expected to increase demand. As healthcare systems continue to grow, inhalation anesthesia will remain a critical component of modern surgical practice.

MARKET SEGMENTATION

By Drug

• Sevoflurane
• Desflurane
• Isoflurane
• Others

By Application

• Induction
• Maintenance

By End-Use

• Hospitals
• Ambulatory Surgical Centers
• Others

COMPANIES PROFILED

• AbbVie Inc, Baxter International Inc, Dechra Pharmaceuticals PLC Halocarbon Life Sciences LLC, Fresenius Kabi AG Fresenius SE Co KGaA, Hikma Pharmaceuticals PLC, Jiangsu Hengrui Medicine Co Ltd, Lunan Pharmaceutical Group Co Ltd, Merck KGaA, Piramal Enterprises Limited, Troikaa Pharmaceuticals Ltd
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL INHALATION ANESTHESIA MARKET: BY DRUG 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Drug
• 4.2. Sevoflurane Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Desflurane Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Isoflurane Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL INHALATION ANESTHESIA MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Induction Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Maintenance Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL INHALATION ANESTHESIA MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL INHALATION ANESTHESIA MARKET: BY REGION 2022-2034 (USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Drug
  • 7.2.2 By Application
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Drug
  • 7.3.2 By Application
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Drug
  • 7.4.2 By Application
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Drug
  • 7.5.2 By Application
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Drug
  • 7.6.2 By Application
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL INHALATION ANESTHESIA INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 AbbVie Inc
  • 9.2.2 Baxter International Inc
  • 9.2.3 Dechra Pharmaceuticals PLC (Halocarbon Life Sciences LLC)
  • 9.2.4 Fresenius Kabi AG (Fresenius SE & Co. KGaA)
  • 9.2.5 Hikma Pharmaceuticals PLC
  • 9.2.6 Jiangsu Hengrui Medicine Co. Ltd
  • 9.2.7 Lunan Pharmaceutical Group Co. Ltd
  • 9.2.8 Merck KGaA
  • 9.2.9 Piramal Enterprises Limited
  • 9.2.10 Troikaa Pharmaceuticals Ltd